Physician profile
Brian Pekkerman
NPI 1629494570
$796.04
in general payments reported to CMS, 2019-2025
11 companies · $49.50 in 2025
The $49.50 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $131 · 2021: $130 · 2022: $162 · 2024: $152 · 2025: $49.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $175.19 | 2020-2024 | Senza |
| Medtronic USA, INC. | $133.86 | 2019-2020 | |
| Baxter Healthcare | $122.06 | 2022 | |
| Boston Scientific Corporation | $88.43 | 2021 | |
| Depuy Synthes Sales INC. | $78.44 | 2021-2025 | Orthovisc, Monovisc |
| Painteq LLC | $55.82 | 2024 | Painteq |
| Vertiflex, INC. | $49.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $45.26 | 2024-2025 | Euflexxa |
| Stryker Corporation | $20.62 | 2021 | |
| Abbvie INC. | $18.59 | 2022 | |
| Spr Therapeutics, INC | $8.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pekkerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.